DDHD1

Chr 14AR

DDHD domain containing 1

Also known as: PA-PLA1, PAPLA1, SPG28, iPLA1I, iPLA1alpha

This gene is a member of the intracellular phospholipase A1 gene family. The protein encoded by this gene preferentially hydrolyzes phosphatidic acid. It is a cytosolic protein with some mitochondrial localization, and is thought to be involved in the regulation of mitochondrial dynamics. Overexpression of this gene causes fragmentation of the tubular structures in mitochondria, while depletion of the gene results in mitochondrial tubule elongation. Deletion of this gene in male mice caused fertility defects, resulting from disruption in the organization of the mitochondria during spermiogenesis. In humans, mutations in this gene have been associated with hereditary spastic paraplegia (HSP), also known as Strumpell-Lorrain disease, or, familial spastic paraparesis (FSP). This inherited disorder is characterized by progressive weakness and spasticity of the legs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.341 OMIM phenotype
Clinical SummaryDDHD1
🧬
Gene-Disease Validity (ClinGen)
hereditary spastic paraplegia · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.90). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
31 unique Pathogenic / Likely Pathogenic· 286 VUS of 592 total submissions
📖
GeneReview available — DDHD1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.34LOEUF
pLI 0.902
Z-score 4.93
OE 0.19 (0.110.34)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
1.18Z-score
OE missense 0.85 (0.790.92)
427 obs / 501.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.19 (0.110.34)
00.351.4
Missense OE?0.85 (0.790.92)
00.61.4
Synonymous OE?1.02
01.21.6
LoF obs/exp: 8 / 42.8Missense obs/exp: 427 / 501.4Syn Z: -0.25
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveDDHD1-related spastic paraplegiaLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.3694th %ile
GOF
0.4579th %ile
LOF
0.65top 25%

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

592 submitted variants in ClinVar

Classification Summary

Pathogenic25
Likely Pathogenic6
VUS286
Likely Benign201
Benign48
Conflicting12
25
Pathogenic
6
Likely Pathogenic
286
VUS
201
Likely Benign
48
Benign
12
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
24
1
0
0
25
Likely Pathogenic
5
1
0
0
6
VUS
3
273
8
2
286
Likely Benign
0
10
77
114
201
Benign
0
5
38
5
48
Conflicting
12
Total32290123121578

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

10 pathogenic / likely-pathogenic (of 14) ClinVar copy-number / structural variants overlap DDHD1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

DDHD1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →